Prudential Financial’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67.1K Buy
+21,790
New +$92.5K ﹤0.01% 2277
2025
Q3
Sell
-11,195
Closed -$43.3K 2420
2025
Q2
$43.3K Buy
+11,195
New +$60.6K ﹤0.01% 2354
2023
Q4
Sell
-333,255
Closed -$866K 2648
2023
Q3
$866K Buy
+333,255
New +$956K ﹤0.01% 1831
2023
Q1
Sell
-110,650
Closed -$1.82M 2603
2022
Q4
$1.82M Buy
+110,650
New +$1.24M ﹤0.01% 1367
2017
Q2
Sell
-100
Closed -$24K 2339
2017
Q1
$24K Sell
100
-4
-4% -$2.14K ﹤0.01% 2318
2016
Q4
$101K Buy
+104
New +$93.2K ﹤0.01% 2292

Other funds holding ALT

Prudential Financial's ALT Position: Q1 2026 in Review

Prudential Financial opened a new position in Altimmune (ALT) in Q1 2026: 21,790 shares worth $67.1K. The stake represents ﹤0.01% of the portfolio and ranks #2277 among its holdings. This is a return to the name: Prudential Financial previously reported a position in ALT as recently as Q2 2025.

Prudential Financial first reported a position in ALT in Q4 2016 and has held it in 6 quarters since. The position peaked at $1.82M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Prudential Financial held 21,790 shares of Altimmune worth $67.1K as of Q1 2026.
  • Altimmune was a new Prudential Financial position in Q1 2026.
  • Altimmune made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2277 holding.
  • Prudential Financial first reported a position in Altimmune in Q4 2016 and has held it in 6 quarters since.
  • Prudential Financial's Altimmune position peaked at $1.82M in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.